As in­sulin prices sky­rock­et, Michi­gan law­mak­ers look to make it in-state

If Cal­i­for­nia can fig­ure out a way to low­er in­sulin prices for its res­i­dents, why can’t Michi­gan do the same?

That’s the mind­set of a group of state law­mak­ers, in­clud­ing Sen. Curt Van­der­Wall, R-Lud­ing­ton. The group has met with drug­mak­ers — in­clud­ing Pfiz­er — and lo­cal uni­ver­si­ties to talk about what it would take to cut the cost of in­sulin for res­i­dents with di­a­betes.

In an in­ter­view with Bridge Michi­gan, Van­der­Wall said that there are two main av­enues to ex­plore. One in­volves bring­ing man­u­fac­tur­ers to the ta­ble and get­ting them to of­fer to sell the drugs at cost. The oth­er in­volves tak­ing the state, and turn­ing it in­to a man­u­fac­tur­er it­self.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER